Atlas Trials

Baxalta now part of Shire

111 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Baxalta now part of Shire

RecordFirmDate
A Study of ADVATE in People With Hemophilia A in India (NCT04985682)Baxalta now part of Shire2022-01-14
A Study to Assess the Tolerability, Safety, and Pharmacokinetics of Subcutaneous Immune Globulin Infusion 10% (Human) With Recombinant Human Hyaluronidase (HYQVIA/HyQvia) With Ramp-up and No Ramp-up Dosing in Healthy Adult Participants (NCT04578535)Baxalta now part of Shire2020-10-27
A Study of Immune Globulin Subcutaneous (Human), 20% Solution (IGSC, 20%) in Japanese Participants With Primary Immunodeficiency Diseases (PID) (NCT04346108)Baxalta now part of Shire2020-08-11
A Phase 1/2 Study of SHP648, an Adeno-Associated Viral Vector for Gene Transfer in Hemophilia B Subjects (NCT04394286)Baxalta now part of Shire2020-05-13
A Study of Recombinant Von Willebrand Factor (rVWF) in Pediatric and Adult Participants With Severe Von Willebrand Disease (VWD) (NCT03879135)Baxalta now part of Shire2019-04-01
FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR) (NCT02764489)Baxalta now part of Shire2019-02-12
RIXUBIS PMS India (RIXUBIS PMS) (NCT03565237)Baxalta now part of Shire2018-12-07
Real-world CANadian CUvitru Non-Interventional Study in Subjects Transitioning From Subcutaneous Immunoglobulin (CANCUN) (NCT03716700)Baxalta now part of Shire2018-09-24
Prospective Psychometric Evaluation Study of a Patient-reported Outcomes (PRO) Instrument for Congenital Thrombotic Thrombocytopenic Purpura (cTTP, Upshaw-Schulman Syndrome [USS], Hereditary Thrombotic Thrombocytopenic Purpura [hTTP] (NCT03519672)Baxalta now part of Shire2018-07-12
A Study of BAX 888 in Male Adults With Severe Hemophilia A (NCT03370172)Baxalta now part of Shire2018-02-27
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD) (NCT02932618)Baxalta now part of Shire2017-11-06
A Study of BAX 930 in Children, Teenagers, and Adults Born With Thrombotic Thrombocytopenic Purpura (TTP) (NCT03393975)Baxalta now part of Shire2017-10-13
Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects (NCT03277313)Baxalta now part of Shire2017-09-25
Next →

Track Baxalta now part of Shire automatically

Every clearance here is in the API, with alerts when new ones post.